ID

14865

Description

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00050141

Link

https://clinicaltrials.gov/show/NCT00050141

Keywords

  1. 5/2/16 5/2/16 -
  2. 6/26/16 6/26/16 -
Uploaded on

May 2, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00050141

Eligibility Breast Cancer NCT00050141

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
locally advanced, inoperable loco-regionally-recurrent, or metastatic breast cancer
Description

ID.1

Data type

boolean

Alias
UMLS CUI [1,1]
C0278493|C0027627
UMLS CUI [1,2]
C0205187
estrogen and/or progesterone positive disease
Description

ID.2

Data type

boolean

Alias
UMLS CUI [1]
C0019929
progression of disease after antiestrogen therapy
Description

ID.3

Data type

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0279025
measurable disease
Description

ID.4

Data type

boolean

Alias
UMLS CUI [1]
C0012634
postmenopausal
Description

ID.5

Data type

boolean

Alias
UMLS CUI [1]
C0232970
eastern cooperative oncology group (ecog) performance status 0, 1, or 2.
Description

ID.6

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous endocrine therapy, other than antiestrogen therapy
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0279025
more than 1 prior chemotherapy regimen
Description

ID.8

Data type

boolean

Alias
UMLS CUI [1]
C0392920
previous therapy with farnesyl transferase inhibitor
Description

ID.9

Data type

boolean

Alias
UMLS CUI [1]
C1517132
presence of rapidly progressive, life-threatening metastases
Description

ID.10

Data type

boolean

Alias
UMLS CUI [1,1]
C2826244
UMLS CUI [1,2]
C0027627
concomitant anticancer treatment
Description

ID.11

Data type

boolean

Alias
UMLS CUI [1]
C0920425
other malignancy within the past 5 years
Description

ID.12

Data type

boolean

Alias
UMLS CUI [1]
C0006826
symptomatic peripheral neuropathy.
Description

ID.13

Data type

boolean

Alias
UMLS CUI [1]
C0031117

Similar models

Eligibility Breast Cancer NCT00050141

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
locally advanced, inoperable loco-regionally-recurrent, or metastatic breast cancer
boolean
C0278493|C0027627 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
ID.2
Item
estrogen and/or progesterone positive disease
boolean
C0019929 (UMLS CUI [1])
ID.3
Item
progression of disease after antiestrogen therapy
boolean
C0242656 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
ID.4
Item
measurable disease
boolean
C0012634 (UMLS CUI [1])
ID.5
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
ID.6
Item
eastern cooperative oncology group (ecog) performance status 0, 1, or 2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
previous endocrine therapy, other than antiestrogen therapy
boolean
C0205394 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
ID.8
Item
more than 1 prior chemotherapy regimen
boolean
C0392920 (UMLS CUI [1])
ID.9
Item
previous therapy with farnesyl transferase inhibitor
boolean
C1517132 (UMLS CUI [1])
ID.10
Item
presence of rapidly progressive, life-threatening metastases
boolean
C2826244 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
ID.11
Item
concomitant anticancer treatment
boolean
C0920425 (UMLS CUI [1])
ID.12
Item
other malignancy within the past 5 years
boolean
C0006826 (UMLS CUI [1])
ID.13
Item
symptomatic peripheral neuropathy.
boolean
C0031117 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial